Probiotic Supplementation Reduces RRTIs and Enhances Gut Microbial and Immunity in Children: A Randomized Controlled Trial
Journal of Microbiology and Biotechnology · 03.02.2026 · 36
DOI: 10.4014/jmb.2511.11038 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Microbiology and Biotechnology, online erschienen am 03.02.2026. Verfasst von Ke Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Chengdu Women's & Children's Central Hospital, School of Medicine, University of Electronic Science and Technology …. Hauptthemen laut MEDLINE: Probiotics, Respiratory Tract Infections, Gastrointestinal Microbiome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shanghai Science and Technology Service Industry.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
< 0.05). Gut microbiota profiling showed clear community differences between groups at day 180, with the probiotic group exhibiting greater abundance of beneficial commensal taxa and the placebo group showing higher representation of opportunistic genera. Functional pathway analysis indicated shifts consistent with enhanced metabolic stability in probiotic recipients. Immune biomarker patterns further supported a more regulated humoral response in the probiotic group, reflected by comparatively stable IgG, IgM, and complement C3 levels over the intervention period. Growth trajectories remained normal in both groups, and no treatment-related adverse events were reported, confirming a favorable safety profile. These findings indicate that long-term supplementation with XLTG11 and CCFM8661 is safe, well tolerated, and effective in reducing RRTI burden in children, while also supporting healthier microbiota and immune patterns. This trial provides evidence for the use of strain-defined probiotics as a complementary approach within pediatric respiratory infection prevention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Nutrition, Chengdu Women's & Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, P.R. China.
- College of Pharmacy, Heilongjiang University of Chinese Medicine, P.R. China.
- Department of Child Health Care, Xindu Maternal and Child Health Care Hospital, P.R. China.
- Laboratory of Microbiology, Immunology, and Metabolism, DiPROBIO (Shanghai) Co., Limited, Shanghai, P.R. China.
- School of Exercise and Nutritional Sciences, San Diego State University, P.R. China.
- Sunflower Pharmaceutical Group Co., Limited, Harbin, P.R. China.
Förderung
- Shanghai Science and Technology Service Industry
Zitieren
APA
Chen, K., Ma, W., Zhong, J., Yang, P., He, N., Li, X., Zhai, Y., Yuan, J., Liong, M. T., Liu, C., & Guan, Y. (2026). Probiotic Supplementation Reduces RRTIs and Enhances Gut Microbial and Immunity in Children: A Randomized Controlled Trial. Journal of Microbiology and Biotechnology, 36. https://doi.org/10.4014/jmb.2511.11038
Vancouver
Chen K, Ma W, Zhong J, Yang P, He N, Li X, et al. Probiotic Supplementation Reduces RRTIs and Enhances Gut Microbial and Immunity in Children: A Randomized Controlled Trial. Journal of Microbiology and Biotechnology. 2026;36. doi:10.4014/jmb.2511.11038
BibTeX
@article{Chen2026,
author = {Chen, Ke and Ma, Weiwei and Zhong, Jiayi and Yang, Ping and He, Nianyang and Li, Xiaohui and Zhai, Yue and Yuan, Jie and Liong, Min-Tze and Liu, Changqi and Guan, Yuxiu},
title = {Probiotic Supplementation Reduces RRTIs and Enhances Gut Microbial and Immunity in Children: A Randomized Controlled Trial},
journal = {Journal of Microbiology and Biotechnology},
year = {2026},
volume = {36},
doi = {10.4014/jmb.2511.11038}
}
EUVIMED